Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today highlighted a legislative proposal contained in the FDA's FY 2027 ...
Santé log

Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing Strategic Partnership with WuXi XDC

CEO Abizer Gaslightwala discusses the Company’s strategic partnership with WuXi XDC and its implications for platform validation and development acceleration. Company highlights ...
Pharmaceutical Commerce

GoodRx and Eli Lilly Partner to Expand Access to Foundayo and Zepbound KwikPen

Lilly's Foundayo and Zepbound KwikPen are now available on GoodRx for self-pay access.